-+ 0.00%
-+ 0.00%
-+ 0.00%

TG THERAPEUTICS INC: Q2 2025 BRIUMVI U.S. NET PRODUCT REVENUE TARGET OF $135 MLN

Reuters·05/05/2025 11:00:02

Please log in to view news